FDA gives COVID drug with Memphis ties fast-track to emergency use

By , Daily Memphian Updated: May 13, 2022 9:24 AM CT | Published: May 12, 2022 3:35 PM CT

The drug was created as an anti-cancer agent in collaboration with GTx, a former Memphis pharmaceutical firm.

Topics

sabizabulin Veru Inc Mitchell Steiner coronavirus COVID-19 GTx ARDS
Jane Roberts

Jane Roberts

Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers business news and features for The Daily Memphian.


Comments

Reading comments and joining the conversation are some of the many benefits of subscribing. Join the conversation by clicking the View Comments button below. Not a subscriber? Click here. 

Our commenting policy can be viewed here